Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer: A North Central Cancer Treatment Group Trial
- Citation:
- Clin Breast Cancer vol 12 (2) 81-86
- Year:
- 2012
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 1
- Parents:
- 787
- Children:
- None
- Pharmas:
- Grants:
- U10 CA180821, 25224
- Corr. Author:
- Authors:
- Winston W. Tan Jacob B. Allred Muhammad Salim Patrick Flynn Paul A. S. Fishkin Philip J. Stella Martin Wiesenfeld Albert M. Bernath Tom R. Fitch Edith A. Perez
- Networks:
- Study
- NCCTG-N0337
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- capecitabine, combination chemotherapy, metastatic breast cancer, trastuzumab, vinorelbine